Red Blood Cell Transfusion in the Intensive Care Unit : vima

Red Blood Cell Transfusion in the Intensive Care Unit

This cohort study evaluates and describes red blood cell transfusion practices in intensive care units worldwide.

Related Keywords

New Zealand , Amsterdam , Noord Holland , Netherlands , New Delhi , Delhi , India , Germany , Scheeren , Sachsen Anhalt , Australia , Noord , Utrecht , Monash , South Australia , Helsinki , Eteläuomen Läi , Finland , United States , America , Australian , Alexander Pj Vlaar , Pierre Fabre Pharma , Edwards Lifesciences Garching , Christopher Seymour , Eli Lilly , Orion Pharma , Fresenius Kabi , Edwards Lifesciences , Ge Healthcare , Research Council , Getinge Group Maquet , Omnicare Clinical Research , Novartis , European Society Of Intensive Care Medicine , Nestle , Boehringer Ingelheim , Kenta Biotech Ltd , National Health , Abbott Nutrition International , Medtronic , National Blood Authority Of Australia , Blood Synergy Monash University , Edwards Lifesciences Services Gmb , Astrazeneca , Group Information , Jaypee Brothers Medical Publishers Pvt Ltd , European Society Of Intensive Medicine , Pfizer , Amsterdam University Medical Centers , Glaxosmithkline , Monash University , Input Study Group , Australian National Blood Authority , World Bank Classification System , Sequential Organ Failure Assessment , International Point Prevalence Study , Intensive Care Unit Transfusion Practices , Bank Classification , Statistical Analyses , South America , North America , European Society , Intensive Medicine , Associate Editor , Intensive Care Medicine , Drs Vlaar , Interest Disclosures , Directed Systems , Medical Research Council , Blood Synergy , Centre Federal , Expertise Belge , Blood Gases , Edwards Lifesciences Services Gmbh , Maquet Critical Care , Bard Medica , Anandic Medical Systems , Japan Gas , Hamilton Medical , Teleflex Medical Gmbh , Merck Sharp , Intensive Care , National Blood Authority , Synergy Grant , Leader Investigator Grant ,

© 2025 Vimarsana